glp-1 agonist drug interactions Drug-Drug Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review | Safety Exploring glucagon-like peptide-1 receptor agonists
Description
Cazzola R, Della Porta M, Piuri G, Maier JA
Such risk factors include early treatment phase, persistent gastrointestinal symptoms such as nausea or vomiting, and comorbid conditions such as diabetic gastroparesis or Parkinsons disease
Although GLP-1RAs have shown remarkable efficacy in weight management, several barriers limit their full integration into mainstream obesity care
Recent trials indicate that these drugs may lead to significant weight loss and metabolic improvements in adolescents and younger children
Nature 489 , 242249 (2012)
Available online: [DOI] [PMC free article] [PubMed] [Google Scholar] 48.Gao J., Long B., Wang Z
